Structure

Physi-Chem Properties

Molecular Weight:  420.08
Volume:  410.823
LogP:  3.488
LogD:  2.455
LogS:  -4.047
# Rotatable Bonds:  4
TPSA:  141.34
# H-Bond Aceptor:  8
# H-Bond Donor:  4
# Rings:  4
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.284
Synthetic Accessibility Score:  2.965
Fsp3:  0.043
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.097
MDCK Permeability:  1.2660013453569263e-05
Pgp-inhibitor:  0.202
Pgp-substrate:  0.972
Human Intestinal Absorption (HIA):  0.046
20% Bioavailability (F20%):  0.89
30% Bioavailability (F30%):  0.997

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.003
Plasma Protein Binding (PPB):  98.47211456298828%
Volume Distribution (VD):  0.397
Pgp-substrate:  4.113518238067627%

ADMET: Metabolism

CYP1A2-inhibitor:  0.909
CYP1A2-substrate:  0.112
CYP2C19-inhibitor:  0.169
CYP2C19-substrate:  0.042
CYP2C9-inhibitor:  0.555
CYP2C9-substrate:  0.795
CYP2D6-inhibitor:  0.131
CYP2D6-substrate:  0.765
CYP3A4-inhibitor:  0.273
CYP3A4-substrate:  0.12

ADMET: Excretion

Clearance (CL):  8.117
Half-life (T1/2):  0.898

ADMET: Toxicity

hERG Blockers:  0.062
Human Hepatotoxicity (H-HT):  0.67
Drug-inuced Liver Injury (DILI):  0.988
AMES Toxicity:  0.163
Rat Oral Acute Toxicity:  0.03
Maximum Recommended Daily Dose:  0.725
Skin Sensitization:  0.794
Carcinogencity:  0.38
Eye Corrosion:  0.004
Eye Irritation:  0.914
Respiratory Toxicity:  0.076

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC300680

Natural Product ID:  NPC300680
Common Name*:   Inoscavin C
IUPAC Name:   3-acetyl-2-(3,4-dihydroxyphenyl)-6-[(E)-2-(3,4-dihydroxyphenyl)ethenyl]furo[3,2-c]pyran-4-one
Synonyms:   Inoscavin C
Standard InCHIKey:  HKRPUELQNBGEIC-GORDUTHDSA-N
Standard InCHI:  InChI=1S/C23H16O8/c1-11(24)20-21-19(31-22(20)13-4-7-16(26)18(28)9-13)10-14(30-23(21)29)5-2-12-3-6-15(25)17(27)8-12/h2-10,25-28H,1H3/b5-2+
SMILES:  Oc1ccc(cc1O)/C=C/c1oc(=O)c2c(c1)oc(c2C(=O)C)c1ccc(c(c1)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL205356
PubChem CID:   44410484
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0001818] Furopyrans

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33057 Inonotus xeranticus Species Hymenochaetaceae Eukaryota n.a. n.a. n.a. PMID[16488146]
NPO33057 Inonotus xeranticus Species Hymenochaetaceae Eukaryota n.a. chonan-si, Korea 2005-APR PMID[16499338]
NPO41437 Inonotus obliquus + Phellinus punctatus Species n.a. n.a. n.a. n.a. n.a. PMID[20830471]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1 Others Radical scavenging activity IC50 > 100000.0 nM PMID[524474]
NPT1 Others Radical scavenging activity IC50 = 7800.0 nM PMID[524474]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC300680 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9805 High Similarity NPC89131
0.9367 High Similarity NPC29411
0.9317 High Similarity NPC47386
0.9141 High Similarity NPC261471
0.9136 High Similarity NPC218533
0.9136 High Similarity NPC78830
0.913 High Similarity NPC86477
0.908 High Similarity NPC247964
0.903 High Similarity NPC164384
0.9024 High Similarity NPC37606
0.8896 High Similarity NPC50394
0.8889 High Similarity NPC291110
0.8882 High Similarity NPC312056
0.8882 High Similarity NPC84515
0.8869 High Similarity NPC97523
0.8862 High Similarity NPC297807
0.8834 High Similarity NPC277480
0.882 High Similarity NPC188486
0.8812 High Similarity NPC244750
0.8773 High Similarity NPC37183
0.8765 High Similarity NPC272722
0.8758 High Similarity NPC115432
0.8758 High Similarity NPC260296
0.8757 High Similarity NPC47883
0.875 High Similarity NPC98546
0.8742 High Similarity NPC99199
0.8742 High Similarity NPC80489
0.8734 High Similarity NPC125300
0.8734 High Similarity NPC41326
0.8727 High Similarity NPC202470
0.8712 High Similarity NPC133065
0.8696 High Similarity NPC16935
0.8696 High Similarity NPC196879
0.8688 High Similarity NPC472461
0.8683 High Similarity NPC473834
0.8683 High Similarity NPC310794
0.8679 High Similarity NPC472462
0.8679 High Similarity NPC72370
0.8675 High Similarity NPC131866
0.8671 High Similarity NPC23668
0.8671 High Similarity NPC193976
0.8671 High Similarity NPC267091
0.8667 High Similarity NPC186392
0.8667 High Similarity NPC247973
0.8659 High Similarity NPC45449
0.8659 High Similarity NPC36320
0.8659 High Similarity NPC39306
0.8659 High Similarity NPC259007
0.8659 High Similarity NPC329215
0.8659 High Similarity NPC204088
0.8659 High Similarity NPC38914
0.8647 High Similarity NPC475996
0.8634 High Similarity NPC268360
0.8623 High Similarity NPC174700
0.8616 High Similarity NPC207624
0.8616 High Similarity NPC60972
0.8616 High Similarity NPC39732
0.8616 High Similarity NPC142308
0.8608 High Similarity NPC230713
0.8608 High Similarity NPC3825
0.8608 High Similarity NPC78335
0.8608 High Similarity NPC243891
0.8608 High Similarity NPC167576
0.8608 High Similarity NPC88804
0.8598 High Similarity NPC155640
0.8598 High Similarity NPC1755
0.8598 High Similarity NPC39305
0.8598 High Similarity NPC1706
0.8598 High Similarity NPC263092
0.8598 High Similarity NPC59295
0.858 High Similarity NPC24258
0.8571 High Similarity NPC45131
0.8571 High Similarity NPC82217
0.8571 High Similarity NPC13879
0.8571 High Similarity NPC216842
0.8571 High Similarity NPC476640
0.8563 High Similarity NPC295436
0.8563 High Similarity NPC120220
0.8562 High Similarity NPC235333
0.8555 High Similarity NPC248315
0.8554 High Similarity NPC470704
0.8554 High Similarity NPC241820
0.8553 High Similarity NPC170169
0.8553 High Similarity NPC58668
0.8553 High Similarity NPC154345
0.8553 High Similarity NPC106372
0.8553 High Similarity NPC115324
0.8547 High Similarity NPC154527
0.8545 High Similarity NPC88243
0.8544 High Similarity NPC178202
0.8537 High Similarity NPC238995
0.8537 High Similarity NPC144843
0.8535 High Similarity NPC17816
0.8535 High Similarity NPC472969
0.8535 High Similarity NPC108406
0.8528 High Similarity NPC328102
0.8528 High Similarity NPC130955
0.8528 High Similarity NPC476283
0.8526 High Similarity NPC70136
0.8526 High Similarity NPC155144
0.8521 High Similarity NPC287243
0.8521 High Similarity NPC227906
0.8519 High Similarity NPC299520
0.8519 High Similarity NPC129684
0.8512 High Similarity NPC472584
0.8512 High Similarity NPC54098
0.8512 High Similarity NPC230619
0.8509 High Similarity NPC4455
0.8509 High Similarity NPC20830
0.8509 High Similarity NPC128863
0.8509 High Similarity NPC183597
0.8509 High Similarity NPC50715
0.8509 High Similarity NPC472280
0.8509 High Similarity NPC268008
0.8509 High Similarity NPC208197
0.8509 High Similarity NPC201136
0.8509 High Similarity NPC196439
0.8509 High Similarity NPC146165
0.8509 High Similarity NPC92659
0.8509 High Similarity NPC227325
0.8509 High Similarity NPC163780
0.8509 High Similarity NPC2476
0.8509 High Similarity NPC256612
0.8509 High Similarity NPC297531
0.8509 High Similarity NPC167815
0.8509 High Similarity NPC148938
0.8509 High Similarity NPC280339
0.8509 High Similarity NPC213936
0.8509 High Similarity NPC138360
0.8503 High Similarity NPC280493
0.85 High Similarity NPC63187
0.85 High Similarity NPC157784
0.85 High Similarity NPC67654
0.85 High Similarity NPC37684
0.8497 Intermediate Similarity NPC226725
0.8494 Intermediate Similarity NPC323137
0.8494 Intermediate Similarity NPC13481
0.8494 Intermediate Similarity NPC207575
0.8491 Intermediate Similarity NPC184136
0.8491 Intermediate Similarity NPC295036
0.8485 Intermediate Similarity NPC272750
0.8485 Intermediate Similarity NPC173729
0.8485 Intermediate Similarity NPC477689
0.8485 Intermediate Similarity NPC134047
0.8485 Intermediate Similarity NPC223006
0.8481 Intermediate Similarity NPC107636
0.8481 Intermediate Similarity NPC12367
0.8481 Intermediate Similarity NPC118726
0.8481 Intermediate Similarity NPC98809
0.8481 Intermediate Similarity NPC476394
0.8476 Intermediate Similarity NPC112418
0.8476 Intermediate Similarity NPC469889
0.8471 Intermediate Similarity NPC8127
0.8471 Intermediate Similarity NPC49667
0.8466 Intermediate Similarity NPC172770
0.8466 Intermediate Similarity NPC185258
0.8462 Intermediate Similarity NPC279121
0.8462 Intermediate Similarity NPC117450
0.8462 Intermediate Similarity NPC233956
0.8457 Intermediate Similarity NPC265511
0.8457 Intermediate Similarity NPC137100
0.8457 Intermediate Similarity NPC472455
0.8457 Intermediate Similarity NPC54928
0.8457 Intermediate Similarity NPC247677
0.8457 Intermediate Similarity NPC160015
0.8457 Intermediate Similarity NPC3980
0.8452 Intermediate Similarity NPC476641
0.8448 Intermediate Similarity NPC139683
0.8448 Intermediate Similarity NPC73929
0.8448 Intermediate Similarity NPC47905
0.8447 Intermediate Similarity NPC475895
0.8447 Intermediate Similarity NPC47781
0.8447 Intermediate Similarity NPC70433
0.8447 Intermediate Similarity NPC227337
0.8447 Intermediate Similarity NPC273462
0.8447 Intermediate Similarity NPC1477
0.8447 Intermediate Similarity NPC250822
0.8447 Intermediate Similarity NPC25127
0.8447 Intermediate Similarity NPC49402
0.8447 Intermediate Similarity NPC75279
0.8447 Intermediate Similarity NPC255350
0.8447 Intermediate Similarity NPC183878
0.8447 Intermediate Similarity NPC160951
0.8447 Intermediate Similarity NPC22519
0.8447 Intermediate Similarity NPC176775
0.8447 Intermediate Similarity NPC89474
0.8447 Intermediate Similarity NPC145379
0.8447 Intermediate Similarity NPC69394
0.8447 Intermediate Similarity NPC274327
0.8447 Intermediate Similarity NPC213608
0.8447 Intermediate Similarity NPC231018
0.8447 Intermediate Similarity NPC170492
0.8447 Intermediate Similarity NPC189130
0.8447 Intermediate Similarity NPC33051
0.8447 Intermediate Similarity NPC287504
0.8447 Intermediate Similarity NPC276409
0.8442 Intermediate Similarity NPC326065
0.8439 Intermediate Similarity NPC71260
0.8438 Intermediate Similarity NPC260895
0.8438 Intermediate Similarity NPC304295

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC300680 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8462 Intermediate Similarity NPD1511 Approved
0.8447 Intermediate Similarity NPD2801 Approved
0.8443 Intermediate Similarity NPD3818 Discontinued
0.8431 Intermediate Similarity NPD2344 Approved
0.8354 Intermediate Similarity NPD1512 Approved
0.8344 Intermediate Similarity NPD3882 Suspended
0.8344 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8333 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8313 Intermediate Similarity NPD6232 Discontinued
0.8293 Intermediate Similarity NPD3749 Approved
0.8282 Intermediate Similarity NPD3817 Phase 2
0.8274 Intermediate Similarity NPD7473 Discontinued
0.8272 Intermediate Similarity NPD1934 Approved
0.8263 Intermediate Similarity NPD3926 Phase 2
0.8217 Intermediate Similarity NPD2309 Approved
0.811 Intermediate Similarity NPD1465 Phase 2
0.8107 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8107 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8107 Intermediate Similarity NPD6166 Phase 2
0.8035 Intermediate Similarity NPD6559 Discontinued
0.8 Intermediate Similarity NPD7819 Suspended
0.7989 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7975 Intermediate Similarity NPD3226 Approved
0.7965 Intermediate Similarity NPD7054 Approved
0.7964 Intermediate Similarity NPD7075 Discontinued
0.7963 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.795 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.795 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7919 Intermediate Similarity NPD7472 Approved
0.7919 Intermediate Similarity NPD7074 Phase 3
0.7917 Intermediate Similarity NPD919 Approved
0.7888 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7879 Intermediate Similarity NPD7411 Suspended
0.7874 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7874 Intermediate Similarity NPD6797 Phase 2
0.787 Intermediate Similarity NPD5494 Approved
0.7862 Intermediate Similarity NPD1243 Approved
0.7857 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7853 Intermediate Similarity NPD920 Approved
0.7831 Intermediate Similarity NPD6801 Discontinued
0.7829 Intermediate Similarity NPD7251 Discontinued
0.7818 Intermediate Similarity NPD4380 Phase 2
0.7812 Intermediate Similarity NPD4628 Phase 3
0.7812 Intermediate Similarity NPD3750 Approved
0.7791 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7785 Intermediate Similarity NPD2935 Discontinued
0.7784 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD6799 Approved
0.7759 Intermediate Similarity NPD5844 Phase 1
0.7756 Intermediate Similarity NPD230 Phase 1
0.7756 Intermediate Similarity NPD447 Suspended
0.775 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7738 Intermediate Similarity NPD5402 Approved
0.773 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7722 Intermediate Similarity NPD2799 Discontinued
0.7722 Intermediate Similarity NPD1510 Phase 2
0.7722 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7719 Intermediate Similarity NPD1247 Approved
0.7711 Intermediate Similarity NPD6599 Discontinued
0.7709 Intermediate Similarity NPD8434 Phase 2
0.7692 Intermediate Similarity NPD7768 Phase 2
0.7692 Intermediate Similarity NPD943 Approved
0.7688 Intermediate Similarity NPD1549 Phase 2
0.7688 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7684 Intermediate Similarity NPD7808 Phase 3
0.7677 Intermediate Similarity NPD3764 Approved
0.7677 Intermediate Similarity NPD2313 Discontinued
0.7673 Intermediate Similarity NPD2796 Approved
0.764 Intermediate Similarity NPD2800 Approved
0.7633 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7633 Intermediate Similarity NPD2296 Approved
0.7627 Intermediate Similarity NPD7685 Pre-registration
0.7625 Intermediate Similarity NPD2346 Discontinued
0.7625 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7625 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7625 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7622 Intermediate Similarity NPD2534 Approved
0.7622 Intermediate Similarity NPD2532 Approved
0.7622 Intermediate Similarity NPD2533 Approved
0.7616 Intermediate Similarity NPD6959 Discontinued
0.7607 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.758 Intermediate Similarity NPD1240 Approved
0.7556 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7546 Intermediate Similarity NPD6190 Approved
0.753 Intermediate Similarity NPD5403 Approved
0.7516 Intermediate Similarity NPD1471 Phase 3
0.7514 Intermediate Similarity NPD7199 Phase 2
0.75 Intermediate Similarity NPD1608 Approved
0.75 Intermediate Similarity NPD6234 Discontinued
0.75 Intermediate Similarity NPD3748 Approved
0.75 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7484 Intermediate Similarity NPD1607 Approved
0.7471 Intermediate Similarity NPD6808 Phase 2
0.7468 Intermediate Similarity NPD1203 Approved
0.7458 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7452 Intermediate Similarity NPD3268 Approved
0.7429 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.741 Intermediate Similarity NPD5401 Approved
0.741 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7378 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7374 Intermediate Similarity NPD5953 Discontinued
0.7355 Intermediate Similarity NPD2797 Approved
0.7351 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7348 Intermediate Similarity NPD8313 Approved
0.7348 Intermediate Similarity NPD8312 Approved
0.7346 Intermediate Similarity NPD1551 Phase 2
0.7338 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7337 Intermediate Similarity NPD4287 Approved
0.7325 Intermediate Similarity NPD6832 Phase 2
0.7312 Intermediate Similarity NPD1933 Approved
0.731 Intermediate Similarity NPD6280 Approved
0.731 Intermediate Similarity NPD6279 Approved
0.731 Intermediate Similarity NPD37 Approved
0.7308 Intermediate Similarity NPD2798 Approved
0.7303 Intermediate Similarity NPD17 Approved
0.7284 Intermediate Similarity NPD4308 Phase 3
0.7284 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7284 Intermediate Similarity NPD7033 Discontinued
0.7283 Intermediate Similarity NPD4965 Approved
0.7283 Intermediate Similarity NPD4967 Phase 2
0.7283 Intermediate Similarity NPD4966 Approved
0.7273 Intermediate Similarity NPD9717 Approved
0.7273 Intermediate Similarity NPD9269 Phase 2
0.7261 Intermediate Similarity NPD9494 Approved
0.7239 Intermediate Similarity NPD5404 Approved
0.7239 Intermediate Similarity NPD5405 Approved
0.7239 Intermediate Similarity NPD5406 Approved
0.7239 Intermediate Similarity NPD5408 Approved
0.7233 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7215 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7207 Intermediate Similarity NPD7228 Approved
0.7207 Intermediate Similarity NPD3751 Discontinued
0.7205 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7202 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7178 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7175 Intermediate Similarity NPD7229 Phase 3
0.7169 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7167 Intermediate Similarity NPD7286 Phase 2
0.7152 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7151 Intermediate Similarity NPD6385 Approved
0.7151 Intermediate Similarity NPD6386 Approved
0.7143 Intermediate Similarity NPD7390 Discontinued
0.7135 Intermediate Similarity NPD5242 Approved
0.7135 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD3266 Approved
0.7134 Intermediate Similarity NPD3267 Approved
0.7126 Intermediate Similarity NPD2354 Approved
0.7125 Intermediate Similarity NPD411 Approved
0.7104 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7091 Intermediate Similarity NPD7266 Discontinued
0.7081 Intermediate Similarity NPD6233 Phase 2
0.7079 Intermediate Similarity NPD5711 Approved
0.7079 Intermediate Similarity NPD5710 Approved
0.7076 Intermediate Similarity NPD1653 Approved
0.707 Intermediate Similarity NPD3225 Approved
0.7069 Intermediate Similarity NPD5760 Phase 2
0.7069 Intermediate Similarity NPD5761 Phase 2
0.7066 Intermediate Similarity NPD8166 Discontinued
0.7063 Intermediate Similarity NPD3027 Phase 3
0.7063 Intermediate Similarity NPD7095 Approved
0.7059 Intermediate Similarity NPD6273 Approved
0.7059 Intermediate Similarity NPD9545 Approved
0.7056 Intermediate Similarity NPD8151 Discontinued
0.7051 Intermediate Similarity NPD3972 Approved
0.7043 Intermediate Similarity NPD8150 Discontinued
0.7037 Intermediate Similarity NPD1613 Approved
0.7037 Intermediate Similarity NPD4307 Phase 2
0.7037 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.703 Intermediate Similarity NPD6100 Approved
0.703 Intermediate Similarity NPD6099 Approved
0.7025 Intermediate Similarity NPD1470 Approved
0.7022 Intermediate Similarity NPD8127 Discontinued
0.7019 Intermediate Similarity NPD6798 Discontinued
0.7016 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7013 Intermediate Similarity NPD9268 Approved
0.6995 Remote Similarity NPD7501 Clinical (unspecified phase)
0.6994 Remote Similarity NPD6355 Discontinued
0.6983 Remote Similarity NPD3787 Discontinued
0.6974 Remote Similarity NPD7435 Discontinued
0.6971 Remote Similarity NPD8455 Phase 2
0.6964 Remote Similarity NPD7003 Approved
0.6964 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6964 Remote Similarity NPD4110 Phase 3
0.6962 Remote Similarity NPD1876 Approved
0.6957 Remote Similarity NPD7039 Approved
0.6957 Remote Similarity NPD7038 Approved
0.6951 Remote Similarity NPD6651 Approved
0.6949 Remote Similarity NPD6971 Discontinued
0.6943 Remote Similarity NPD1481 Phase 2
0.6936 Remote Similarity NPD7458 Discontinued
0.6932 Remote Similarity NPD4288 Approved
0.6923 Remote Similarity NPD7177 Discontinued
0.6918 Remote Similarity NPD1164 Approved
0.6907 Remote Similarity NPD6781 Approved
0.6907 Remote Similarity NPD6778 Approved
0.6907 Remote Similarity NPD6782 Approved
0.6907 Remote Similarity NPD6780 Approved
0.6907 Remote Similarity NPD6777 Approved
0.6907 Remote Similarity NPD6776 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data